Table 4.
Total femur BMD (gm/cm2) | Femoral neck BMD (gm/cm2) | Intertrochanter BMD (gm/cm2) | L1 BMD (gm/cm2) | |
---|---|---|---|---|
50–60 years | ||||
Non-aspirin users | Reference | Reference | Reference | Reference |
Low-dose aspirin users | 0.020 (− 0.010, 0.049) P = 0.1907 | 0.026 (− 0.004, 0.056) P = 0.0931 | 0.028 (− 0.008, 0.064) P = 0.1289 | 0.026 (− 0.007, 0.059) P = 0.1190 |
60–70 years | ||||
Non-aspirin users | Reference | Reference | Reference | Reference |
Low-dose aspirin users | 0.037 (0.013, 0.061) P = 0.0024 | 0.014 (− 0.011, 0.040) P = 0.2614 | 0.047 (0.018, 0.077) P = 0.0015 | 0.029 (− 0.004, 0.062) P = 0.0887 |
70–80 years | ||||
Non-aspirin users | Reference | Reference | Reference | Reference |
Low-dose aspirin users | 0.010 (− 0.019, 0.039) P = 0.4979 | 0.013 (− 0.013, 0.039) P = 0.3352 | 0.008 (− 0.028, 0.044) P = 0.6663 | 0.011 (− 0.030, 0.052) P = 0.5989 |
P interaction | P = 0.3347 | P = 0.7506 | P = 0.2308 | P = 0.7528 |
Gender, Race, Heart attack, Vigorous work activity, BMI, Hba1c, Education level, Ratio of family income to poverty, Fractures, Anti-osteoporotic, Prednisone or Cortisone, HS C-Reactive Protein, Smoking status, Serum Creatinine, Serum Uric acid, Alcohol consumption were adjusted.